11448 Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

RPE-funded Health Departments (State, DC, and 

Territories) and their Designated Delegates.

Annual Reporting—Initial Population ......................

Annual Reporting—Subsequent Reporting .............

53 

53 

1 

2 

4 

2 

212 

212 

Total ................................................................. ................................................................................. .................... ........................ .................... 424 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–04192 Filed 2–28–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CK–22– 

006, Clinical and Applied Research 

Strategies for the Prevention and 

Control of Fungal Diseases; 

Cancellation of Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services. 

ACTION: Notice. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given of a change in the meeting 

of the Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CK–22– 

006, Clinical and Applied Research 

Strategies for the Prevention and 

Control of Fungal Diseases; April 14, 

2022, 10:00 a.m.–5:00 p.m., EDT. The 

teleconference was published in the 

Federal Register on February 14, 2022, 

Volume 87, Number 30, page 8251. 

This meeting is being canceled in its 

entirety. 

FOR FURTHER INFORMATION CONTACT: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, 1600 Clifton Road 

NE, Mailstop US8–1, Atlanta, Georgia 

30329, (404) 718–8833, ganderson@

cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–04259 Filed 2–28–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3427–N] 

Medicare Program; Request for 

Nominations for Members for the 

Medicare Evidence Development & 

Coverage Advisory Committee 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

request for nominations for membership 

on the Medicare Evidence Development 

& Coverage Advisory Committee 

(MEDCAC). Among other duties, the 

MEDCAC provides advice and guidance 

to the Secretary of the Department of 

Health and Human Services (the 

Secretary) and the Administrator of the 

Centers for Medicare & Medicaid 

Services (CMS) concerning the 

adequacy of scientific evidence 

available to CMS in making coverage 

determinations under the Medicare 

program. The MEDCAC’s fundamental 

purpose is to support the principles of 

an evidence-based determination 

process for Medicare’s coverage 

policies. MEDCAC panels provide 

advice to CMS on the strength of the 

evidence available for specific medical 

treatments and technologies through a 

public, participatory, and accountable 

process. 

DATES: Nominations must be received 

by Monday, March 28, 2022. 

ADDRESSES: You may mail nominations 

for membership to the following 

address: Centers for Medicare & 

Medicaid Services, Center for Clinical 

Standards and Quality, Attention: Ruth 

McKesson, 7500 Security Boulevard, 

Mail Stop: S3–02–01, Baltimore, MD 

21244 or send via email to 

MEDCACnomination@cms.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Ruth McKesson, MEDCAC Coordinator, 

Centers for Medicare & Medicaid 

Services, Center for Clinical Standards 

and Quality, Coverage and Analysis 

Group, S3–02–01, 7500 Security 

Boulevard, Baltimore, MD 21244 or 

contact Ms. McKesson by phone (410) 

786–8611 or via email at 

Ruth.McKesson@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Secretary signed the initial 

charter for the Medicare Coverage 

Advisory Committee (MCAC) on 

November 24, 1998. A notice in the 

Federal Register (63 FR 68780) 

announcing establishment of the MCAC 

was published on December 14, 1998. 

The MCAC name was updated to more 

accurately reflect the purpose of the 

committee and on January 26, 2007, the 

Secretary published a notice in the 

Federal Register (72 FR 3853), 

announcing that the Committee’s name 

changed to the Medicare Evidence 

Development & Coverage Advisory 

Committee (MEDCAC). The current 

Secretary’s Charter for the MEDCAC is 

available on the CMS website at: https:// 

www.cms.gov/Regulations-andGuidance/Guidance/FACA/Downloads/ 

medcaccharter.pdf or you may obtain a 

copy of the charter by submitting a 

request to the contact listed in the FOR

FURTHER INFORMATION section of this 

notice. 

The MEDCAC is governed by 

provisions of the Federal Advisory 

Committee Act, Public Law 92–463, as 

amended (5 U.S.C. App. 2), which sets 

forth standards for the formulation and 

use of advisory committees, and is 

authorized by section 222 of the Public 

Health Service Act as amended (42 

U.S.C. 217A). 

We are requesting nominations for 

candidates to serve on the MEDCAC. 

Nominees are selected based upon their 

individual qualifications and not solely 

as representatives of professional 

associations or societies. We wish to 


jspears on DSK121TN23PROD with NOTICES1